etavopivat B 10042 clinical trials

A Single Arm, Open Label, Phase 1/2 Study to Evaluate the Pharmacokinetics and Safety of Etavopivat in Pediatric Patients with Sickle Cell Disease

This study is testing a new medicine called etavopivat for children and young people with sickle cell disease. It aims to see how safe the medicine is, how it moves through the body, and if it helps improve their health, especially by increasing healthy red blood cells.